This site is intended for health professionals only

Echocardiography ‘can predict trastuzumab AEs’

teaser

Article continues below this sponsored advert
Featured Image
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
Advertisement

Echocardiography has a central role to play in identifying patients at risk of suffering heart damage from cancer therapies, and also in evaluating potential cardio protective treatments, according to the findings of two studies presented at the “EUROECHO and other Imaging Modalities” 2011 Congress in Budapest, Hungary.

One study reported on an initiative using echocardiography to document early warning signs of adverse effects from trastuzumab (Herceptin






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x